Cutler Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,408
Closed -$21K 3701
2022
Q4
$21K Buy
1,408
+1,044
+287% +$490K ﹤0.01% 2168
2022
Q3
$11K Sell
364
-296
-45% -$177K ﹤0.01% 3041
2022
Q2
$9K Buy
660
+512
+346% +$259K ﹤0.01% 3250
2022
Q1
$10K Buy
148
+100
+208% +$51.5K ﹤0.01% 3585
2021
Q4
$5K Hold
48
﹤0.01% 4143
2021
Q3
$7K Buy
+48
New +$41K ﹤0.01% 4183

Other funds holding AGL

Cutler Group's AGL Position: Q2 2023 in Review

Cutler Group sold out of Agilon Health (AGL) in Q2 2023, closing a stake of 123 shares — an estimated $69.1K sold.

Cutler Group first reported a position in AGL in Q3 2021 and held it in 7 quarters. The position peaked at $194K in Q4 2022. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Cutler Group reported no remaining Agilon Health position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 123 Agilon Health shares in Q2 2023, an estimated $69.1K.
  • Cutler Group first reported a position in Agilon Health in Q3 2021 and held it in 7 quarters.
  • Cutler Group's Agilon Health position peaked at $194K in Q4 2022.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.